TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive In Brief: NCCS to hold Candlelight Vigil Sept. 25; Moffit Wins Chemistry-Biology Grants September 17, 1999
TCL Archive Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around December 7, 1979